Maravai LifeSciences Holdings Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
All right. Thank you for joining us. We'll kick off our next session. My name is Mike Ryskin. I'm on the life science tools and diagnostics team here at BofA. I'm joined by the session by Juan Avendano and the team.
And joining us as well, we have Kevin Herde and Deb Hart from Maravai. So I think to begin, we're going to go through some slides, just sort of set the background a little bit, and then we'll hop into a fireside chat after that.
So Kevin, off to you.
Great. Thanks, Michael. It's a pleasure to present Maravai to you. For those who don't know the story, we went to public in November of 2020 and just recently reported our first quarter results this Monday.
On Slide 2, just to start, we will talk about certain forward-looking statements and non-GAAP measures, primarily adjusted EBITDA and some disclosures related to that.
Then I'll move to Slide 3 and kind of just talk about
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |